Compare H2O America (HTO) vs Neurocrine Biosciences Inc (NBIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
H2O America vs Neurocrine Biosciences Inc — how do they compare? H2O America trades at $63.79 (market cap $2.70B), while Neurocrine Biosciences Inc trades at $179 (market cap $17.40B). The key difference: Neurocrine Biosciences Inc is far larger — about 6.4× H2O America's market cap, and H2O America pays a 2.73% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.
| HTO | NBIX | |
|---|---|---|
Market Cap | $2.70B | $17.40B |
Sector | Technology | Health |
52-Week High | $65.43 | $180.55 |
52-Week Low | $44.44 | $123.10 |
Enterprise Value | $4.42B | $16.49B |
Dividend Yield | 2.73% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About H2O America
H2O America is a utility company that provides essential water and wastewater services, primarily in the United States. The company operates a network of regulated water and wastewater systems, focusing on responsible resource management and high-quality service delivery. HTO aims to expand its operational footprint through acquisitions and internal growth, serving residential, commercial, and industrial customers.
Read more on HTO →About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →
